Abivax SA (ABVX) is trading at $102.99 down 1.95% over the past 24 hours. Its Galaxy Score is 64.9, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 198.9K engagements and 305 posts with 75% positive social sentiment.
LunarCrush tracks live social sentiment, mentions, news, and influencer activity for Abivax SA (ABVX) across X, Reddit, StockTwits, YouTube, and news. Follow how conversation around ABVX is shifting alongside price, Galaxy Score, social dominance, market cap, and 24-hour engagements and mentions. This is the social intelligence snapshot for Abivax SA (ABVX): who is talking, how they feel, and how loud the conversation is right now. Numbers update throughout the day as new posts, news headlines, and creator activity land. Read this page as the Abivax SA (ABVX) briefing: live market context, social volume, and the tone of the conversation in one snapshot.
AI summary: ABVX S.A. (ABVX) is a French clinical-stage biotech developing obefazimod for ulcerative colitis and IBD Recent slide and sell pressure, combined with social dominance surging 174% and retail buying, suggest a potential bottoming out for ABVX